{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T06:31:14Z","timestamp":1769063474820,"version":"3.49.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,10,12]],"date-time":"2024-10-12T00:00:00Z","timestamp":1728691200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,10,12]],"date-time":"2024-10-12T00:00:00Z","timestamp":1728691200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Health Popul Nutr"],"DOI":"10.1186\/s41043-024-00649-6","type":"journal-article","created":{"date-parts":[[2024,10,12]],"date-time":"2024-10-12T16:02:03Z","timestamp":1728748923000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Comparative clinical trial of Langenlianqiao oral liquid and Lianhuaqingwen capsule in the treatment of mild cases of coronavirus disease 2019 (COVID-19)"],"prefix":"10.1186","volume":"43","author":[{"given":"Yan-Mo","family":"Yang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qin-Xuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi-Zhao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mi","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,10,12]]},"reference":[{"issue":"8","key":"649_CR1","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1056\/NEJMoa2001017","volume":"382","author":"N Zhu","year":"2020","unstructured":"Zhu N, Zhang D, Wang W, et al. A novel coronavirus from patients with Pneumonia in China, 2019. N Engl J Med. 2020;382(8):727\u201333.","journal-title":"N Engl J Med"},{"issue":"4","key":"649_CR2","first-page":"5","volume":"39","author":"YQ Gu","year":"2021","unstructured":"Gu YQ. Research progress on chemical composition and clinical efficacy of Lianhua Qingwen Capsule, a traditional Chinese medicine for fighting COVID-19. J Pharm Pract. 2021;39(4):5.","journal-title":"J Pharm Pract"},{"issue":"10256","key":"649_CR3","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1016\/S0140-6736(20)31862-6","volume":"396","author":"RHM Furtado","year":"2020","unstructured":"Furtado RHM, Berwanger O, Fonseca HA, et al. Azithromycin in addition to standard of care versus standard of care alone in the treatment of patients admitted to the hospital with severe COVID-19 in Brazil (COALITION II): a randomised clinical trial. Lancet. 2020;396(10256):959\u201367.","journal-title":"Lancet"},{"issue":"21","key":"649_CR4","doi-asserted-by":"publisher","first-page":"2030","DOI":"10.1056\/NEJMoa2022926","volume":"383","author":"P Horby","year":"2020","unstructured":"Horby P, Mafham M, Linsell L, et al. Effect of Hydroxychloroquine in hospitalized patients with Covid-19. N Engl J Med. 2020;383(21):2030\u201340.","journal-title":"N Engl J Med"},{"issue":"5","key":"649_CR5","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1177\/1740774520943846","volume":"17","author":"BL Houston","year":"2020","unstructured":"Houston BL, Lawler PR, Goligher EC, et al. Anti-thrombotic therapy to Ameliorate complications of COVID-19 (ATTACC): study design and methodology for an international, adaptive bayesian randomized controlled trial. Clin Trials. 2020;17(5):491\u2013500.","journal-title":"Clin Trials"},{"issue":"1","key":"649_CR6","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1186\/s12879-020-05698-w","volume":"20","author":"M Nojomi","year":"2020","unstructured":"Nojomi M, Yassin Z, Keyvani H, et al. Effect of Arbidol (Umifenovir) on COVID-19: a randomized controlled trial. BMC Infect Dis. 2020;20(1):954.","journal-title":"BMC Infect Dis"},{"issue":"10236","key":"649_CR7","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.1016\/S0140-6736(20)31022-9","volume":"395","author":"Y Wang","year":"2020","unstructured":"Wang Y, Zhang D, Du G, et al. Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial. Lancet. 2020;395(10236):1569\u201378.","journal-title":"Lancet"},{"issue":"12","key":"649_CR8","first-page":"881","volume":"18","author":"Y-JD \u2206","year":"2020","unstructured":"\u2206 Y-JD, \u2206 S-YW, Gong SS, et al. Recent advances of traditional Chinese medicine on the prevention and treatment of COVID-19 - ScienceDirect. Chin J Nat Med. 2020;18(12):881\u20139.","journal-title":"Chin J Nat Med"},{"key":"649_CR9","first-page":"142","volume-title":"The mechanisms and clinical application of traditional Chinese Medicine Lianhua-Qingwen capsule[J]","author":"F Yin","year":"2021","unstructured":"Yin F, Shen X. The mechanisms and clinical application of traditional Chinese Medicine Lianhua-Qingwen capsule. Biomed Pharmacother . 2021;142."},{"key":"649_CR10","doi-asserted-by":"crossref","unstructured":"Huang K, Zhang P, Zhang Z et al. Traditional Chinese medicine (TCM) in the treatment of viral infections: efficacies and mechanisms. Pharmacol [?] Ther, 2021, (7647): 107843.","DOI":"10.1016\/j.pharmthera.2021.107843"},{"key":"649_CR11","unstructured":"Daily C, Homepage. https:\/\/covid-19.chinadaily.com.cn\/a\/202003\/24\/WS5e795bb6a3101282172816c2.html"},{"key":"649_CR12","doi-asserted-by":"crossref","unstructured":"Ren JL, Zhang AH, Wang XJ. Traditional Chinese medicine for COVID-19 treatment[J]. Pharmacol Res, 2020, 155104743.","DOI":"10.1016\/j.phrs.2020.104743"},{"issue":"3","key":"649_CR13","first-page":"371","volume":"19","author":"XJ Sun","year":"2024","unstructured":"Sun XJ, Wei KH. Network pharmacology analysis of effective ingredients of traditional Chinese medicine for the treatment of novel coronavirus infection. Chin J Pathogenic Biology. 2024;19(3):371\u20132.","journal-title":"Chin J Pathogenic Biology"},{"issue":"12","key":"649_CR14","first-page":"2222","volume":"42","author":"L Liu","year":"2022","unstructured":"Liu L, Wang N, Xu DK, et al. The mechanism of traditional Chinese medicine preparation in the treatment of COVID-19. Chem Life. 2022;42(12):2222\u201330.","journal-title":"Chem Life"},{"issue":"4","key":"649_CR15","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1007\/s11655-020-3192-6","volume":"26","author":"H Luo","year":"2020","unstructured":"Luo H, Tang QL, Shang YX, et al. Can Chinese Medicine be used for Prevention of Corona Virus Disease 2019 (COVID-19)? A review of historical classics, Research Evidence and current Prevention Programs[J]. Chin J Integr Med. 2020;26(4):243\u201350.","journal-title":"Chin J Integr Med"},{"issue":"7","key":"649_CR16","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1016\/j.apsb.2020.06.002","volume":"10","author":"AJZ B YXA","year":"2020","unstructured":"B YXA AJZ, C ZB, et al. Bioactive natural compounds against human coronaviruses: a review and perspective. Acta Pharm Sinica B. 2020;10(7):1163\u201374.","journal-title":"Acta Pharm Sinica B"},{"key":"649_CR17","doi-asserted-by":"crossref","unstructured":"Ye M, Luo G, Ye D et al. Network pharmacology, molecular docking integrated surface plasmon resonance technology reveals the mechanism of Toujie Quwen granules against coronavirus disease 2019 pneumonia[J]. Phytomedicine, 2020, 153401.","DOI":"10.1016\/j.phymed.2020.153401"},{"issue":"1","key":"649_CR18","doi-asserted-by":"publisher","first-page":"116","DOI":"10.3390\/molecules22010116","volume":"22","author":"L Zhengtu","year":"2017","unstructured":"Zhengtu L, Li L, Hongxia Z, et al. Radix Isatidis Polysaccharides inhibit Influenza a Virus and Influenza A Virus-Induced inflammation via suppression of host TLR3 signaling in Vitro. Molecules. 2017;22(1):116.","journal-title":"Molecules"},{"key":"649_CR19","unstructured":"Wu FF, Liu LJ, Tan ZE et al. Research progress on antiviral pharmacological effects and clinical applications of Lianhua Qingwen capsules (granules)[J]. Drug Evaluation Research, 2024, (5)."},{"key":"649_CR20","unstructured":"Diagnosis and Treatment Program for Novel Coronavirus Infections (Trial Ninth Edition.). http:\/\/www.nhc.gov.cn\/yzygj\/s7653p\/202203\/a354cb3151b74cfdbac6b2e909f311e6.shtml"},{"key":"649_CR21","unstructured":"Diagnostic Program for New Coronavirus Pneumonia (Ninth Edition.). http:\/\/www.nhc.gov.cn\/cms-search\/downFiles\/ef09aa4070244620b010951b088b8a27.pdf?eqid=c0b5e5f70000092b000000066449e9bb"},{"issue":"2","key":"649_CR22","doi-asserted-by":"publisher","first-page":"100952","DOI":"10.1016\/j.imr.2023.100952","volume":"12","author":"X Yu","year":"2023","unstructured":"Yu X, Wu S, Zhang J, et al. Developing TCM clinical practice guidelines: a comparison between traditional Chinese medicine and western medicine. Integr Med Res. 2023;12(2):100952.","journal-title":"Integr Med Res"},{"issue":"4","key":"649_CR23","first-page":"540","volume":"33","author":"YW Ding","year":"2016","unstructured":"Ding YW, Zeng LJ, Li RF, et al. Research on the pharmacodynamic effect of Lianhua Qingwen granules against respiratory syncytial virus infection in BALB\/c mice . J Guangzhou Univ Chin Med. 2016;33(4):540\u20134.","journal-title":"J Guangzhou Univ Chin Med"},{"key":"649_CR24","doi-asserted-by":"crossref","unstructured":"A SZ, C JPBB. A SL, Network pharmacology analysis of the therapeutic mechanisms of the traditional Chinese herbal formula Lian Hua Qing Wen in Corona virus disease 2019 (COVID-19), gives fundamental support to the clinical use of LHQW - ScienceDirect. Phytomedicine, 2020, 79.","DOI":"10.1016\/j.phymed.2020.153336"},{"issue":"1","key":"649_CR25","first-page":"5","volume":"18","author":"HY Mo","year":"2007","unstructured":"Mo HY, Ke CW, Zheng JP, et al. Experimental study on the anti-influenza a virus effect of Lianhua Qingwen capsule in vitro. Chin Traditional Med New Drugs Clin Pharmacol. 2007;18(1):5.","journal-title":"Chin Traditional Med New Drugs Clin Pharmacol"},{"issue":"3","key":"649_CR26","first-page":"7","volume":"35","author":"N Sheng","year":"2020","unstructured":"Sheng N, Lu GJ, Fu Y, et al. Research on the impact of forsythiaside A on the toll-like receptor 4 signaling pathway in mice infected with H9N2 avian influenza . J Beijing Univ Agric. 2020;35(3):7.","journal-title":"J Beijing Univ Agric"},{"issue":"08","key":"649_CR27","first-page":"2015","volume":"51","author":"JH Xu","year":"2020","unstructured":"Xu JH, Xue Y, Zhang W, et al. Exploration of the molecular mechanism of Shu Feng Jie Du capsule in the treatment of new coronavirus pneumonia (COVID-19) based on network pharmacology . Chin Traditional Herb Drugs. 2020;51(08):2015\u201323.","journal-title":"Chin Traditional Herb Drugs"},{"issue":"6","key":"649_CR28","first-page":"3","volume":"20","author":"W Jia","year":"2018","unstructured":"Jia W, Mao SM, Zhang PP, et al. Research on the in vivo antiviral effect of honeysuckle polysaccharides . J Liaoning Univ Traditional Chin Med. 2018;20(6):3.","journal-title":"J Liaoning Univ Traditional Chin Med"},{"issue":"04","key":"649_CR29","first-page":"263","volume":"31","author":"S Chen","year":"2021","unstructured":"Chen S, Wang J, Wu DL, et al. Exploration of the molecular mechanism of the monarch drug in Lianhua Qingwen for the treatment of COVID-19 based on network pharmacology . Pharm Today. 2021;31(04):263\u201370.","journal-title":"Pharm Today"}],"container-title":["Journal of Health, Population and Nutrition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41043-024-00649-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s41043-024-00649-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41043-024-00649-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,12]],"date-time":"2024-10-12T16:03:31Z","timestamp":1728749011000},"score":1,"resource":{"primary":{"URL":"https:\/\/jhpn.biomedcentral.com\/articles\/10.1186\/s41043-024-00649-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,12]]},"references-count":29,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["649"],"URL":"https:\/\/doi.org\/10.1186\/s41043-024-00649-6","relation":{},"ISSN":["2072-1315"],"issn-type":[{"value":"2072-1315","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,12]]},"assertion":[{"value":"6 December 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 September 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 October 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was conducted in accordance with the Declaration of Helsinki and approved by the ethics committee of Changde Hospital (ethical batch number: YX-2023-119-01), and informed consent was obtained from all participants.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"158"}}